Bemer Therapy System Evo - English; Table of Contents

Translation of the original instructions for use
BEMER Int. AG
Austrasse 15
LI-9495 Triesen
www.bemergroup.com
Tel.:+423 399 39 99
Fax:+423 399 39 98
Collection ID 2590, Version 11
Date: 06/2022
Table of Contents
1. General information 6
1.1 Instructions for use 7
1.2 Symbols 8
1.3 Liability 9
1.4 Copyright notice 9
1.5 Warranty 10
1.6 Notification of incidents 10
2. Safety 11
2.1 Intended use 11
2.1.1 Intended purpose 11
2.1.2 Medical applications 11
2.1.3 Indications for use 11
2.1.4 Contraindications 12
2.1.5 Potential side effects 12
2.1.6 Intended use 13
2.1.7 Intended users 13
2.1.8 Intended patient group 14
2.1.9 Body regions 14
2.1.10 Intended environment and field of application 14
2.2 Clinical benefits 14
2.3 General safety instructions 15
2.4 Medical notes 20
2.4.1 Medical notes on PEMF 20
2.4.2 Medical notes on LLLT 21
2.5 Notes for professional users of medical products 22
2.6 Safety labels 22
2.7 Protective equipment 23
2.8 Environmental protection 23
3. Technical data 24
3.1 Storage, transport, and operating conditions 24
3.2 Product-specific technical data 25
3.3 EMC conformity 32
Instructions for use
Emergo Consulting (UK) Limited
c/o Cr360 — UL
International
Compass House, Vision Park Histon
Cambridge CB24 9BZ
United Kingdom
Phone: +44(0) 1223 772 671
Email: UKRPvigilance@ul.com
FR EN
32